AGX three-lens brief
Evidence-based stock research on AGX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price up 5.78% in the last session — a material single-day move. · Trading at 13% of its 52-week range — deep in the lower band.
- Price up 5.78% in the last session — a material single-day move.
- Trading at 13% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 14.4pp over 30 days.
- Analyst mean target $570.50 — 77% above current (6 analysts).
AGX closed at $322.00 (+5.78%) as of 2026-11-12. Market cap: $4.52B. P/E (trailing) 25.5. Price is below the 50-day MA and below the 200-day MA. Positives: price up 5.78% in the last session — a material single-day move.; analyst mean target $570.50 — 77% above current (6 analysts).. Concerns: trading at 13% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $383.98M, net income $53.30M, free cash flow $467.82M. Watching for: 2026-12-03 earnings release (21 days out).
Why three lenses on AGX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AGX across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AGX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AGX brief"></iframe>